Joslin Diabetes Center announces Joslin Institute for Technology Translation, with Dexcom as Founding Member
Joslin Diabetes Center recently announced the Joslin Institute for Technology Translation (JITT), a new division formalizing the delivery of Joslin’s clinical solutions to medical device and technology companies. WLSA member Dexcom, Inc., a maker of continuous glucose monitoring systems for patients and blood glucose monitoring systems for healthcare providers in hospital settings, became the first Founding Member of the JITT and member of the JITT Advisory Board.
“Dexcom is honored to join as the premiere partner with the Joslin Institute for Technology Translation, collaborating to share best medical practices and advanced technological innovations for patients with diabetes and the health care practitioners who treat them,” said Terrance H. Gregg, CEO of Dexcom. “Daily management of diabetes is imperative, and Dexcom continues its commitment to effective diabetes management through our new role in partnership with Joslin’s Institute.”
“The value of using technology to improve patient care with a chronic condition like diabetes cannot be overstated, “ said Howard Wolpert, M.D., director of JITT. “I look forward to working with our partners, starting with Dexcom, to make clinical recommendations to significantly compliment technology for improved patient care on a worldwide basis.”